Role of RNA modifications in cancer - PubMed (original) (raw)
Review
. 2020 Jun;20(6):303-322.
doi: 10.1038/s41568-020-0253-2. Epub 2020 Apr 16.
Affiliations
- PMID: 32300195
- DOI: 10.1038/s41568-020-0253-2
Review
Role of RNA modifications in cancer
Isaia Barbieri et al. Nat Rev Cancer. 2020 Jun.
Abstract
Specific chemical modifications of biological molecules are an efficient way of regulating molecular function, and a plethora of downstream signalling pathways are influenced by the modification of DNA and proteins. Many of the enzymes responsible for regulating protein and DNA modifications are targets of current cancer therapies. RNA epitranscriptomics, the study of RNA modifications, is the new frontier of this arena. Despite being known since the 1970s, eukaryotic RNA modifications were mostly identified on transfer RNA and ribosomal RNA until the last decade, when they have been identified and characterized on mRNA and various non-coding RNAs. Increasing evidence suggests that RNA modification pathways are also misregulated in human cancers and may be ideal targets of cancer therapy. In this Review we highlight the RNA epitranscriptomic pathways implicated in cancer, describing their biological functions and their connections to the disease.
Similar articles
- Deciphering the Epitranscriptomic Signatures in Cell Fate Determination and Development.
Haran V, Lenka N. Haran V, et al. Stem Cell Rev Rep. 2019 Aug;15(4):474-496. doi: 10.1007/s12015-019-09894-3. Stem Cell Rev Rep. 2019. PMID: 31123982 Review. - Role of RNA modifications in brain and behavior.
Jung Y, Goldman D. Jung Y, et al. Genes Brain Behav. 2018 Mar;17(3):e12444. doi: 10.1111/gbb.12444. Genes Brain Behav. 2018. PMID: 29244246 Free PMC article. Review. - The non-coding epitranscriptome in cancer.
Miano V, Codino A, Pandolfini L, Barbieri I. Miano V, et al. Brief Funct Genomics. 2021 Mar 27;20(2):94-105. doi: 10.1093/bfgp/elab003. Brief Funct Genomics. 2021. PMID: 33564819 Free PMC article. Review. - Genetic and epigenetic defects of the RNA modification machinery in cancer.
Orsolic I, Carrier A, Esteller M. Orsolic I, et al. Trends Genet. 2023 Jan;39(1):74-88. doi: 10.1016/j.tig.2022.10.004. Epub 2022 Nov 12. Trends Genet. 2023. PMID: 36379743 Review. - RNA m6 A methylation in cancer.
Wang Z, Zhou J, Zhang H, Ge L, Li J, Wang H. Wang Z, et al. Mol Oncol. 2023 Feb;17(2):195-229. doi: 10.1002/1878-0261.13326. Epub 2022 Nov 6. Mol Oncol. 2023. PMID: 36260366 Free PMC article. Review.
Cited by
- M7G-related tumor immunity: novel insights of RNA modification and potential therapeutic targets.
Han M, Huang Q, Li X, Chen X, Zhu H, Pan Y, Zhang B. Han M, et al. Int J Biol Sci. 2024 Jan 27;20(4):1238-1255. doi: 10.7150/ijbs.90382. eCollection 2024. Int J Biol Sci. 2024. PMID: 38385078 Free PMC article. Review. - Do RNA modifications contribute to modulation of immune responses in allergic diseases?
Kudrin P, Rebane A. Kudrin P, et al. Front Allergy. 2023 Nov 13;4:1277244. doi: 10.3389/falgy.2023.1277244. eCollection 2023. Front Allergy. 2023. PMID: 38026133 Free PMC article. Review. - NSUN6 Regulates NM23-H1 Expression in an m5C Manner to Affect Epithelial-Mesenchymal Transition in Lung Cancer.
Lu Z, Liu B, Kong D, Zhou X, Pei D, Liu D. Lu Z, et al. Med Princ Pract. 2024;33(1):56-65. doi: 10.1159/000535479. Epub 2023 Nov 29. Med Princ Pract. 2024. PMID: 38029727 Free PMC article. - RNA modification-mediated mRNA translation regulation in liver cancer: mechanisms and clinical perspectives.
Lin S, Kuang M. Lin S, et al. Nat Rev Gastroenterol Hepatol. 2024 Apr;21(4):267-281. doi: 10.1038/s41575-023-00884-y. Epub 2024 Jan 19. Nat Rev Gastroenterol Hepatol. 2024. PMID: 38243019 Review. - 5-Methylcytosine Related LncRNAs Reveal Immune Characteristics, Predict Prognosis and Oncology Treatment Outcome in Lower-Grade Gliomas.
Zhang J, Wang N, Wu J, Gao X, Zhao H, Liu Z, Yan X, Dong J, Wang F, Ba Y, Ma S, Jin J, Du J, Ji H, Hu S. Zhang J, et al. Front Immunol. 2022 Mar 3;13:844778. doi: 10.3389/fimmu.2022.844778. eCollection 2022. Front Immunol. 2022. PMID: 35309316 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
- RG86786/CRUK_/Cancer Research UK/United Kingdom
- 27321/CRUK_/Cancer Research UK/United Kingdom
- 092096/WT_/Wellcome Trust/United Kingdom
- C6946/A14492/CRUK_/Cancer Research UK/United Kingdom
- RG17001/CRUK_/Cancer Research UK/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources